共 50 条
- [21] High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma NetworkJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 479 - +Hermine, OlivierJiang, LinmiaoWalewski, JanBosly, AndreThieblemont, CatherineSzymczyk, MichalPott, ChristianeSalles, GillesFeugier, PierreHubel, KaiHaioun, CorinneCasasnovas, Rene OlivierSchmidt, ChristianBouabdallah, KamalRibrag, VincentKanz, LotharDurig, JanMetzner, BerndSibon, DavidCheminant, MorganeBurroni, BarbaraKlapper, WolframHiddemann, WolfgangUnterhalt, MichaelHoster, EvaDreyling, Martin
- [22] Rituximab Combined with Chemotherapy and Acalabrutinib Prior to Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: The Rectangle TrialBLOOD, 2023, 142Villa, DiegoLarouche, Jean-FrancoisCheung, Matthew C.Keating, Mary-MargaretZukotynski, KatherineTonseth, PetterMayo, SamanthaLaister, RobertScott, David W.Kuruvilla, John
- [23] Phase II Trial of Bortezomib Plus Rituximab As Maintenance Therapy Post ASCT for Patients with Mantle Cell LymphomaBLOOD, 2017, 130Chen, Robert W.Palmer, Joycelynne M.Popplewell, LeslieAlluin, JessicaChomchan, PritsanaNademanee, Auayporn P.Siddiqi, TanyaTsai, NicoleZuo, FayAbary, RosieCai, Ji-lianRosen, Steven T.Forman, Stephen J.Kwak, Larry W.Holmberg, Leona
- [24] A multi center trial of hyperCVAD plus rituxan in patients with newly diagnosed mantle cell lymphomaBLOOD, 2007, 110 (11) : 121A - 121AEpner, Elliot M.Unger, JosephMiller, ThomasRimza, LisaSpier, CatherineLeblanc, MichaelFisher, Richard
- [25] Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphomaANNALS OF ONCOLOGY, 2015, 26 (11) : 2323 - 2328Graf, S. A.Stevenson, P. A.Holmberg, L. A.Till, B. G.Press, O. W.Chauncey, T. R.Smith, S. D.Philip, M.Orozco, J. J.Shustov, A. R.Green, D. J.Libby, E. N., IIIBensinger, W. I.Pagel, J. M.Maloney, D. G.Zhou, Y.Cassaday, R. D.Gopal, A. K.
- [26] Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphomaHAEMATOLOGICA, 2006, 91 (03) : 425 - 426de Guibert, SophieJaccard, ArnaudBernard, MarcTurlure, PascaleBordessoule, DominiqueLamy, Thierry
- [27] Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantationJOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11Chen, Robert W.Palmer, Joycelynne M.Tomassetti, SarahPopplewell, Leslie L.Alluin, JessicaChomchan, PritsanaNademanee, Auayporn P.Siddiqi, TanyaTsai, Ni-ChunChen, LuZuo, FayAbary, RosemarieCai, Ji-LianHerrera, Alex F.Rossi, John J.Rosen, Steven T.Forman, Stephen J.Kwak, Larry W.Holmberg, Leona A.
- [28] Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantationJournal of Hematology & Oncology, 11Robert W. ChenJoycelynne M. PalmerSarah TomassettiLeslie L. PopplewellJessica AlluinPritsana ChomchanAuayporn P. NademaneeTanya SiddiqiNi-Chun TsaiLu ChenFay ZuoRosemarie AbaryJi-lian CaiAlex F. HerreraJohn J. RossiSteven T. RosenStephen J. FormanLarry W. KwakLeona A. Holmberg
- [29] Autologous Stem Cell Transplant: Still the Standard for Fit Patients With Mantle Cell LymphomaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S96 - S99Staton, Ashley D.Langston, Amelia A.
- [30] Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphomaANNALS OF ONCOLOGY, 2010, 21 (06) : 1203 - 1210Kasamon, Y. L.Jones, R. J.Brodsky, R. A.Fuchs, E. J.Matsui, W.Luznik, L.Powell, J. D.Blackford, A. L.Goodrich, A.Gocke, C. D.Abrams, R. A.Ambinder, R. F.Flinn, I. W.